Cargando…
MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
In spite of the significant advancements in the treatment modalities, 30% of advanced stage ovarian cancer (OC) patients do not respond to the standard chemotherapeutic regimen and most of the responders finally relapse over time due to the escalation of multidrug resistance (MDR) Phenomenon. Our pr...
Autores principales: | Haque, Absarul, Sait, Khalid Hussain Wali, Alam, Qamre, Alam, Mohammad Zubair, Anfinan, Nisreen, Wali, Abdul Wahab Noor, Rasool, Mahmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264409/ https://www.ncbi.nlm.nih.gov/pubmed/32528530 http://dx.doi.org/10.3389/fgene.2020.00516 |
Ejemplares similares
-
Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2019) -
Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia
por: Sait, Khalid H., et al.
Publicado: (2022) -
Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2020) -
Cytokines secreted by human Wharton's jelly stem cells inhibit the proliferation of ovarian cancer (OVCAR3) cells in vitro
por: Kalamegam, Gauthaman, et al.
Publicado: (2019) -
Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach
por: Haque, Absarul, et al.
Publicado: (2022)